While SGLT2 inhibitors are generally well tolerated, their use has been associated with cases of ketoacidosis. It is therefore important to make patients aware of what steps they can take to minimise the risk of this potentially serious adverse effect.
No takes yet. Share an insight, caveat, or question.
Angus Thompson (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: